SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Culver who wrote (1068)4/19/1999 8:45:00 PM
From: Intrepid1  Read Replies (1) of 1185
 
David, Here is the news FWIW... might explain the recent weakness!

Nortran Pharmaceuticals Inc -

Nortran Pharmaceuticals extends option with F.
Hoffmann-La Roche

Nortran Pharmaceuticals Inc
NRT
Shares issued 27,451,299
1999-04-16 close $1
Monday Apr 19 1999
Mr. Bob Rieder reports
F. Hoffmann-La Roche (Roche) has agreed to finance
$100,000 (U.S.) of further research at Nortran. Roche will
also finance continuing research in Roche laboratories and at
independent research institutes.
In return for this additional payment, Nortran has agreed to
grant Roche an extension to the existing option agreement
announced in May 1998. Roche's option on Nortran's
intellectual property will now expire on or before June 15,
1999.
The original option agreement granted Roche the right to test
four of Nortran's antiarrhythmic compounds for the prevention
and treatment of atrial arrhythmias. Since the execution of the
original option agreement, Roche has financed Nortran's direct
research expenses on the atrial antiarrhythmic project, in
addition to financing external research contracts.
WARNING: The company relies upon litigation protection for
"forward-looking" statements.
(c) Copyright 1999 Canjex Publishing Ltd.
canada-stockwatch.com

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News